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Background & Objectives: In the last decade, Acinetobacter baumannii  have become one 
of the most important pathogens responsible for nosocomial infections, especially in 
Intensive Care Unit patients. The emergence and rapid spread of carbapenem-resistant 
Acinetobacter baumannii has been reported worldwide. From  August 2011 to September 
2012  a nosocomial outbreak has been  occurred in ICU wards of a central teaching hospital , 
caused prolonged hospitalization and considerable morbidity. The purpose of the present 
study was to investigate phenotypic characterization of Acinetobacter baumannii isolated 
from clinical and environmental specimens obtained during the time of the study.  
Methods: A total of 60 non-duplicate Acinetobacter baumani isolates were collected from 
clinical and environmental specimens of central teaching  hospital  between August 2011 and 
September 2012. All isolates were identified  as  Acinetobacter baumannii  by standard 
biochemical tests and  microgen kit (microgen bioproducts).  In addition phenotypical 
characterization of  A. baumannii was confirmed by the presence of 16S–23S rRNA specific 
gene intergenic spacer (ITS). Susceptibilities of the bacterial isolates to panel 22 
antimicrobial agents (Mast ,UK) were tested using the standard disk diffusion methods 
according to Clinical and Laboratory Standards Institute(CLSI-2011 ), European Committee 
on Antimicrobial Susceptibility  Testing(Ucast-2011) and British Society for Antimicrobial 
Chemotherapy (BSAC-2011) guideline. 
Results: Acinetobacter baumannii isolates showed high rate of resistant to ceftazidime 
(100%), cefotaxime (100%), cefepime(100%), cefoxitin(100%), chloramphenicol(100%), 
ciprofloxacin(100%), levofloxacin(100%), erythromycin(100%), clindamaycin(100%) , 
rifampicin(100%), ceftriaxone(100%), aztreonam(100%), piperacillin(100%), 
piperacillin/tazobactam(100%), Trimethoprim-sulfamethoxazole(100%), gentamicin(98.3%), 
meropenem(96.6%), tigecycline(91.6%), imipenem(86.6%), tetracycline(84%), 
amikacin(84%). Nevertheless netilmicin and colistin illustrated 57% and 7% respectively.  
Conclusion: High prevalence extensively drug resistant (XDR) strains in this hospital 
indicating the antibiotic resistant is a major concern, hence antibiotic prescription policy 
should be revised and infection control measure is necessary to be improved. 
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